Amy L. Parkhill, Ph.D.
Affiliations: | 2003 | University of Rochester, Rochester, NY |
Area:
PharmacologyGoogle:
"Amy Parkhill"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Jean M. Bidlack | grad student | 2003 | Rochester | |
| (Investigation of the possible cellular mechanisms of delta-opioid receptor subtype-pharmacology.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bidlack JM, Khimich M, Parkhill AL, et al. (2006) Opioid receptors and signaling on cells from the immune system. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 1: 260-9 |
| Wentland MP, VanAlstine M, Kucejko R, et al. (2006) Redefining the structure-activity relationships of 2,6-methano-3- benzazocines. 4. Opioid receptor binding properties of 8-[n-(4′-phenyl)- phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine Journal of Medicinal Chemistry. 49: 5635-5639 |
| Parkhill AL, Bidlack JM. (2006) Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50,488 in a mouse monocyte-like cell line. International Immunopharmacology. 6: 1013-9 |
| Bidlack JM, Parkhill AL. (2004) Assay of G protein-coupled receptor activation of G proteins in native cell membranes using [35S]GTP gamma S binding. Methods in Molecular Biology (Clifton, N.J.). 237: 135-43 |
| Parkhill AL, Bidlack JM. (2002) Several delta-opioid receptor ligands display no subtype selectivity to the human delta-opioid receptor. European Journal of Pharmacology. 451: 257-64 |